Endogenous interleukin-22 protects against inflammatory bowel disease but not autoimmune cholangitis in dominant negative form of transforming growth factor beta receptor type II mice.
Clin Exp Immunol
; 185(2): 154-64, 2016 08.
Article
in En
| MEDLINE
| ID: mdl-27148790
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Autoimmune Diseases
/
Inflammatory Bowel Diseases
/
Cholangitis
/
Interleukins
/
Receptors, Transforming Growth Factor beta
Type of study:
Prognostic_studies
Limits:
Animals
Language:
En
Journal:
Clin Exp Immunol
Year:
2016
Document type:
Article
Affiliation country:
United States
Country of publication:
United kingdom